Cargando…

Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome

BACKGROUND: Betatrophin has been recently reported to play a role in glucose homeostasis by inducing beta-cell proliferation in mice. However, studies in human are inconsistent. As a nutritionally-regulated liver-enriched factor, we hypothesize that betatrophin might be regulated by vitamin D, and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Junling, Hou, Cong, Li, Lujiao, Feng, Dan, Li, Ge, Li, Mingyao, Li, Changhong, Gao, Shan, Li, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054537/
https://www.ncbi.nlm.nih.gov/pubmed/27716289
http://dx.doi.org/10.1186/s12933-016-0461-y
_version_ 1782458620210839552
author Fu, Junling
Hou, Cong
Li, Lujiao
Feng, Dan
Li, Ge
Li, Mingyao
Li, Changhong
Gao, Shan
Li, Ming
author_facet Fu, Junling
Hou, Cong
Li, Lujiao
Feng, Dan
Li, Ge
Li, Mingyao
Li, Changhong
Gao, Shan
Li, Ming
author_sort Fu, Junling
collection PubMed
description BACKGROUND: Betatrophin has been recently reported to play a role in glucose homeostasis by inducing beta-cell proliferation in mice. However, studies in human are inconsistent. As a nutritionally-regulated liver-enriched factor, we hypothesize that betatrophin might be regulated by vitamin D, and ignorance of vitamin D status may explain the discrepancy in previous human studies. The aims of this study were to assess the association between circulating betatrophin and glucose homeostasis as well as other cardiometabolic variables in a cohort of youths at risk for metabolic syndrome and test the possible influence of vitamin D status on the association. METHODS: 559 subjects aged 14–28 years were recruited from Beijing children and adolescents metabolic syndrome study. All underwent a 2 h-oral glucose tolerance test. Serum levels of betatrophin, 25-hydroxy-vitamin D as well as adipokines including adiponectin and fibroblast growth factor 21 (FGF21) were measured by immunoassays. The relationships between betatrophin and insulin resistance, beta-cell function, other cardiometabolic variables and vitamin D status were evaluated. RESULTS: Participants in the highest quartile of betatrophin levels had the highest levels of total cholesterol (P < 0.001), triglyceride (P < 0.001) and low-density lipoprotein cholesterol (P < 0.001) and the lowest levels of vitamin D (P = 0.003). After stratification by vitamin D status, betatrophin in subjects with vitamin D deficiency were positively correlated with unfavorable metabolic profiles including high blood pressures, dyslipidemia and hyperglycemia, whereas betatrophin in those with higher vitamin D levels only showed negative association with fasting insulin, 2 h-insulin, and insulin resistance. In addition, adiponectin and FGF21 demonstrated the expected associations with metabolic parameters. CONCLUSIONS: Elevated betatrophin levels were associated with cardiometabolic risk factors in this young population, but the association was largely dependent on vitamin D status. These findings may provide valuable insights in the regulation of betatrophin and help explain the observed discrepancies in literature. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-016-0461-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5054537
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50545372016-10-19 Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome Fu, Junling Hou, Cong Li, Lujiao Feng, Dan Li, Ge Li, Mingyao Li, Changhong Gao, Shan Li, Ming Cardiovasc Diabetol Original Investigation BACKGROUND: Betatrophin has been recently reported to play a role in glucose homeostasis by inducing beta-cell proliferation in mice. However, studies in human are inconsistent. As a nutritionally-regulated liver-enriched factor, we hypothesize that betatrophin might be regulated by vitamin D, and ignorance of vitamin D status may explain the discrepancy in previous human studies. The aims of this study were to assess the association between circulating betatrophin and glucose homeostasis as well as other cardiometabolic variables in a cohort of youths at risk for metabolic syndrome and test the possible influence of vitamin D status on the association. METHODS: 559 subjects aged 14–28 years were recruited from Beijing children and adolescents metabolic syndrome study. All underwent a 2 h-oral glucose tolerance test. Serum levels of betatrophin, 25-hydroxy-vitamin D as well as adipokines including adiponectin and fibroblast growth factor 21 (FGF21) were measured by immunoassays. The relationships between betatrophin and insulin resistance, beta-cell function, other cardiometabolic variables and vitamin D status were evaluated. RESULTS: Participants in the highest quartile of betatrophin levels had the highest levels of total cholesterol (P < 0.001), triglyceride (P < 0.001) and low-density lipoprotein cholesterol (P < 0.001) and the lowest levels of vitamin D (P = 0.003). After stratification by vitamin D status, betatrophin in subjects with vitamin D deficiency were positively correlated with unfavorable metabolic profiles including high blood pressures, dyslipidemia and hyperglycemia, whereas betatrophin in those with higher vitamin D levels only showed negative association with fasting insulin, 2 h-insulin, and insulin resistance. In addition, adiponectin and FGF21 demonstrated the expected associations with metabolic parameters. CONCLUSIONS: Elevated betatrophin levels were associated with cardiometabolic risk factors in this young population, but the association was largely dependent on vitamin D status. These findings may provide valuable insights in the regulation of betatrophin and help explain the observed discrepancies in literature. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-016-0461-y) contains supplementary material, which is available to authorized users. BioMed Central 2016-10-06 /pmc/articles/PMC5054537/ /pubmed/27716289 http://dx.doi.org/10.1186/s12933-016-0461-y Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Investigation
Fu, Junling
Hou, Cong
Li, Lujiao
Feng, Dan
Li, Ge
Li, Mingyao
Li, Changhong
Gao, Shan
Li, Ming
Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome
title Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome
title_full Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome
title_fullStr Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome
title_full_unstemmed Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome
title_short Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome
title_sort vitamin d modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054537/
https://www.ncbi.nlm.nih.gov/pubmed/27716289
http://dx.doi.org/10.1186/s12933-016-0461-y
work_keys_str_mv AT fujunling vitamindmodifiestheassociationsbetweencirculatingbetatrophinandcardiometabolicriskfactorsamongyouthsatriskformetabolicsyndrome
AT houcong vitamindmodifiestheassociationsbetweencirculatingbetatrophinandcardiometabolicriskfactorsamongyouthsatriskformetabolicsyndrome
AT lilujiao vitamindmodifiestheassociationsbetweencirculatingbetatrophinandcardiometabolicriskfactorsamongyouthsatriskformetabolicsyndrome
AT fengdan vitamindmodifiestheassociationsbetweencirculatingbetatrophinandcardiometabolicriskfactorsamongyouthsatriskformetabolicsyndrome
AT lige vitamindmodifiestheassociationsbetweencirculatingbetatrophinandcardiometabolicriskfactorsamongyouthsatriskformetabolicsyndrome
AT limingyao vitamindmodifiestheassociationsbetweencirculatingbetatrophinandcardiometabolicriskfactorsamongyouthsatriskformetabolicsyndrome
AT lichanghong vitamindmodifiestheassociationsbetweencirculatingbetatrophinandcardiometabolicriskfactorsamongyouthsatriskformetabolicsyndrome
AT gaoshan vitamindmodifiestheassociationsbetweencirculatingbetatrophinandcardiometabolicriskfactorsamongyouthsatriskformetabolicsyndrome
AT liming vitamindmodifiestheassociationsbetweencirculatingbetatrophinandcardiometabolicriskfactorsamongyouthsatriskformetabolicsyndrome